Andrew Chen

Andrew joined Health Advances in 2020. He has experience in market analysis, competitive assessment, commercial forecasting, and due diligence in international and APAC markets.

Prior to joining Health Advances, Andrew worked as a Regional Regulatory Affairs Specialist at Fresenius Kabi Asia Pacific Ltd. and held various intern positions at Pfizer Corporation Hong Kong Ltd., Hospital Authority Hong Kong, Tuen Mun Hospital, Boehringer Ingelheim Hong Kong Ltd., and The University of Hong Kong - Shen Zhen Hospital.

Andrew holds a BPharm and is a registered pharmacist from The University of Hong Kong.